Clinical Trial Update: Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating elective para-aortic radiotherapy for patients with pN1 prostate cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING